CABERGOLINE

CABERGOLINE: CABERGOLINE is a medication used to treat hyperprolactinemia, a condition characterized by an overproduction of the hormone prolactin. It is also used in the treatment of disorders caused by high levels of prolactin, such as prolactinomas (benign tumors of the pituitary gland), menstrual irregularities, and infertility.

The drug works by stimulating dopamine receptors in the brain, inhibiting the release of prolactin. This helps to reduce the production and secretion of prolactin, normalizing hormone levels in the body.

The recommended starting dose of cabergoline for most conditions is 0.25 mg twice a week. The dose may be increased gradually, up to a maximum of 1 mg twice a week, according to the patient’s response and prolactin levels. It is important to follow the instructions of the healthcare provider regarding the dosage.

Common side effects of cabergoline may include nausea, vomiting, dizziness, headache, fatigue, and constipation. These side effects are usually mild and temporary. In rare cases, more serious side effects such as hallucinations, confusion, and low blood pressure may occur. If any severe side effects are experienced, it is important to seek medical attention immediately.

It is worth noting that cabergoline may interact with certain medications, such as erythromycin, antipsychotics, and medications that affect blood pressure. Therefore, it is important to inform the healthcare provider about any other medications being taken.

Overall, cabergoline is an effective medication for treating hyperprolactinemia and related conditions. However, it is essential to consult with a healthcare provider before starting the treatment to ensure its suitability and to monitor for any potential side effects.